Sin Cars Industry AD (BUL:SIN)
0.3680
0.00 (0.00%)
At close: Jul 28, 2025
Ligand Pharmaceuticals Revenue
In the year 2024, Sin Cars Industry AD had annual revenue of 7.61M BGN with 34.98% growth. Sin Cars Industry AD had revenue of 4.95M in the half year ending December 31, 2024, with 208.79% growth.
Revenue
7.61M
Revenue Growth
+34.98%
P/S Ratio
0.99
Revenue / Employee
27.59K
Employees
276
Market Cap
7.56M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.61M | 1.97M | 34.98% |
Dec 31, 2023 | 5.64M | 3.73M | 195.34% |
Dec 31, 2022 | 1.91M | 695.00K | 57.20% |
Dec 31, 2021 | 1.22M | 960.00K | 376.47% |
Dec 31, 2020 | 255.00K | 72.00K | 39.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shelly Group SE | 220.30M |
Tchaikapharma High Quality Medicines AD | 55.97M |
Sopharma AD | 2.27B |
Speedy AD | 525.58M |
First Investment Bank AD | 456.76M |
Eurohold Bulgaria AD | 3.03B |
M+S Hydraulic AD | 144.34M |
Smart Organic AD | 99.16M |